Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) price closed higher on Tuesday, May 20, and jumping 12.41% above its previous close.
A look at the daily price movement shows that the last close reads $26.60, with intraday deals fluctuated between $25.11 and $30.74. The company’s 5Y monthly beta was ticking 1.64. Taking into account the 52-week price action we note that the stock hit a 52-week high of $659.20 and 52-week low of $6.76. The stock added 99.87% on its value in the past month.
Tonix Pharmaceuticals Holding Corp, which has a market valuation of $219.01 million, is expected to release its quarterly earnings report on 2025-May-11.
Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.On the technical perspective front, indicators give TNXP a short term outlook of Hold on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Sell, while an average of long term indicators are currently assigning the stock as 50% Buy.
Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Specifically, 5 analysts have assigned TNXP a recommendation rating as follows: 1 rate it as a Hold; 4 advise Buy while 0 analyst(s) assign an Overweight rating. 0 analyst(s) have tagged the Tonix Pharmaceuticals Holding Corp (TNXP) stock as Underweight, with 0 recommending Sell. In general, analysts have rated the stock Buy, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares.
The overview shows that TNXP’s price is at present 46.95% off the SMA20 and 55.21% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 75.59, with weekly volatility standing at 15.50%. The indicator jumps to 10.44% when calculated based on the past 30 days. Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)’s beta value is holding at 1.85, while the average true range (ATR) indicator is currently reading 2.67.
An analysis of the Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) stock in terms of its daily trading volume indicates that the 3-month average is 1.34 million. However, this figure increases on the past 10-day timeline to an average of 1.0 million.
Current records show that the company has 7.32M in outstanding shares. The insiders’ percentage holdings are 0.07% of outstanding shares while the percentage share held by institutions stands at 6.78%. The stats also highlight that short interest as of 2025-04-30, stood at 0.98 million shares, which puts the short ratio at the time at 1.18. From this we can glean that short interest is 1419.00 of company’s current outstanding shares. Notably, we see that shares short in April rose slightly given the previous month’s figure stood at 0.92 million. But the -9.34% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
